US Patent Issued to KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION, KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION on March 11 for "Pharmaceutical composition for prevention or treatment of circadian rhythm-related disorders, comprising oxyiminomethylbenzene derivative as active ingredient" (South Korean Inventors)

ALEXANDRIA, Va., March 12 -- United States Patent no. 12,246,002, issued on March 11, was assigned to KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION (Seoul, South Korea) and KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (Daegu, South Korea).

"Pharmaceutical composition for prevention or treatment of circadian rhythm-related disorders, comprising oxyiminomethylbenzene derivative as active ingredient" was invented by Gi Hoon Son (Seoul, South Korea) and Jong Hwa Jung (Daegu, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a pharmaceutical composition for prevention or treatment of circadian rhythm-related disorders, including an oxyiminom...